A detailed history of Sage Rhino Capital LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Sage Rhino Capital LLC holds 10,608 shares of MRK stock, worth $1.34 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
10,608
Previous 10,407 1.93%
Holding current value
$1.34 Million
Previous $1.13 Million 23.37%
% of portfolio
0.34%
Previous 0.28%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

BUY
$113.24 - $131.95 $22,761 - $26,521
201 Added 1.93%
10,608 $1.4 Million
Q4 2023

Feb 05, 2024

SELL
$100.18 - $109.02 $1,302 - $1,417
-13 Reduced 0.12%
10,407 $1.13 Million
Q3 2023

Oct 26, 2023

BUY
$102.95 - $114.33 $3,191 - $3,544
31 Added 0.3%
10,420 $1.07 Million
Q2 2023

Jul 31, 2023

SELL
$108.61 - $118.38 $3,909 - $4,261
-36 Reduced 0.35%
10,389 $1.2 Million
Q1 2023

Apr 20, 2023

SELL
$102.94 - $114.86 $12,661 - $14,127
-123 Reduced 1.17%
10,425 $1.11 Million
Q4 2022

Jan 31, 2023

BUY
$87.44 - $112.11 $2,098 - $2,690
24 Added 0.23%
10,548 $1.17 Million
Q3 2022

Oct 24, 2022

SELL
$84.53 - $94.96 $6,339 - $7,121
-75 Reduced 0.71%
10,524 $906,000
Q2 2022

Jul 28, 2022

BUY
$83.49 - $94.64 $11,271 - $12,776
135 Added 1.29%
10,599 $966,000
Q1 2022

Apr 27, 2022

BUY
$73.51 - $82.4 $3,528 - $3,955
48 Added 0.46%
10,464 $859,000
Q4 2021

Feb 04, 2022

BUY
$72.28 - $90.54 $4,553 - $5,704
63 Added 0.61%
10,416 $798,000
Q3 2021

Oct 18, 2021

BUY
$71.68 - $78.83 $4,515 - $4,966
63 Added 0.61%
10,353 $778,000
Q2 2021

Jul 27, 2021

BUY
$70.31 - $77.77 $10,757 - $11,898
153 Added 1.51%
10,290 $800,000
Q1 2021

May 04, 2021

SELL
$68.86 - $81.11 $550 - $648
-8 Reduced 0.08%
10,137 $781,000
Q4 2020

Feb 03, 2021

BUY
$71.77 - $79.65 $4,808 - $5,336
67 Added 0.66%
10,145 $830,000
Q3 2020

Nov 05, 2020

BUY
$73.18 - $82.95 $1,390 - $1,576
19 Added 0.19%
10,078 $836,000
Q2 2020

Jul 30, 2020

SELL
$70.42 - $80.13 $985 - $1,121
-14 Reduced 0.14%
10,059 $778,000
Q1 2020

Apr 29, 2020

SELL
$63.36 - $87.82 $3,421 - $4,742
-54 Reduced 0.53%
10,073 $775,000
Q4 2019

Jan 31, 2020

BUY
$77.58 - $87.54 $3,801 - $4,289
49 Added 0.49%
10,127 $907,000
Q3 2019

Oct 25, 2019

BUY
$76.08 - $82.93 $2,282 - $2,487
30 Added 0.3%
10,078 $848,000
Q2 2019

Aug 20, 2019

BUY
$69.84 - $81.59 $69 - $81
1 Added 0.01%
10,048 $843,000
Q1 2019

Apr 18, 2019

BUY
$69.58 - $79.36 $699,070 - $797,329
10,047 New
10,047 $836,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $320B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Sage Rhino Capital LLC Portfolio

Follow Sage Rhino Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Rhino Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Rhino Capital LLC with notifications on news.